Beckman Coulter feto-maternal hemorrhage, sepsis and infection tests

Wednesday, 24 November, 2010 | Supplied by: Beckman Coulter Australia


Beckman Coulter has entered into a strategic alliance with Trillium Diagnostics LLC, under the terms of which Beckman Coulter will market specific products in North America and South America and in the majority of Europe, Asia and Australasia.

Trillium Diagnostics products covered in this agreement include assays for feto-maternal hemorrhage testing (FETALtrol control) and cellular HbF level quantitation (FMH QuikQuant), as well as Leuko64, which is used for sepsis and infection detection by flow cytometry.

Adding these products to the Beckman Coulter line for flow cytometry will enable the company to provide diagnostic laboratories and research institutes with targeted flow cytometry products that address specific, unmet medical needs.

Online: www.beckman.com.au
Phone: 1800 060 878
Related Products

Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium

The products provide researchers and manufacturers with high-performance, scalable and...

Grace Bio-Labs protein microarray tools

Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...

Siemens Healthineers 3gAllergy assay

Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd